Clinical Pharmacy infectious diseases

leishmaniasis

Topic overview

Start with the big picture

Phlebotomine sandflies transmit Leishmania, with exposure risk increased by outdoor activity from dusk to dawn. Species clusters help orient the clinical picture: the L. donovani complex is associated with visceral disease, while other species are linked to Old-World cutaneous or New-World cutaneous and mucocutaneous syndromes. Diagnosis includes demonstrating amastigotes in tissue, with PCR or rk39 antigen serology used to confirm visceral disease. Treatment varies by syndrome and context: visceral disease has several systemic regimens, selected cutaneous lesions may be treated locally, and mucocutaneous disease requires systemic therapy. Important medication risks include cardiac, renal, hepatic, pancreatic, and infusion-related effects, so treatment selection and monitoring are central themes.

Learning objectives

What you'll learn

  • Relate major Leishmania species clusters to their associated clinical syndromes.
  • Describe the role of tissue examination and confirmatory tests in diagnosis.
  • Distinguish treatment approaches for visceral, cutaneous, and mucocutaneous disease.
  • Identify key adverse effects and monitoring considerations for major therapies.
Ready for the complete lesson?

Continue your study

Work through the complete notes and reinforce the topic with the study tools available in the full lesson.

PharmaProLearn

Excel Beyond Limits